Healthcare Pharmaceutical Distribution Solutions sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Healthcare Pharmaceutical Distribution Solutions
1.1 - About Healthcare Pharmaceutical Distribution Solutions sector
Companies in Healthcare Pharmaceutical Distribution Solutions source, warehouse, and deliver branded, generic, and specialty medications to care settings nationwide. They manage procurement, inventory, compliance, and last‑mile logistics to ensure safe, on‑time supply. Using secure cold‑chain networks and traceability standards, distributors help pharmacies, hospitals, and providers maintain product integrity and availability while optimizing purchasing and reducing operational risk.
These distributors provide wholesale drug distribution and specialty biologics handling supported by validated cold‑chain logistics. They offer automated order fulfillment, inventory optimization programs, DSCSA track‑and‑trace and serialization, and returns management. Many operate 3PL services and channel management for manufacturers, including launch support and specialty pharmacy networks. Additional capabilities include controlled‑substance compliance, unit‑dose repackaging, chargeback reconciliation, and data analytics for demand forecasting and shelf‑level accuracy.
Primary customers include retail and specialty pharmacies, hospitals and health systems, and biopharma manufacturers seeking outsourced distribution. Outcomes typically include assured product availability and fewer stockouts, compliant handling and traceability, lower total procurement costs through purchasing programs and contract management, and faster time‑to‑patient for specialty therapies. Buyers also benefit from reduced working capital tied up in inventory and improved service levels across multi‑site operations.
2. Buyers in the Healthcare Pharmaceutical Distribution Solutions sector
2.1 Top strategic acquirers of Healthcare Pharmaceutical Distribution Solutions companies
Pfizer
HQ: United States
Website
- Description: Provider of innovative biopharmaceutical solutions that discover, develop and manufacture medicines, vaccines and consumer health products. The company applies science and global resources to create therapies that extend and improve lives, setting standards for quality, safety and value while collaborating with stakeholders worldwide to expand access to reliable, affordable healthcare.
- Key Products:
- Pfizer RxPathways: Patient assistance platform connecting eligible individuals to insurance support, co-pay relief and free or discounted Pfizer medicines, improving affordability and access
- Pfizer Clinical Trials: Global research program partnering with thousands of study sites and participants to conduct clinical studies that produce life-changing medicines and therapeutic breakthroughs
- Global Supply Network: Worldwide manufacturing and logistics infrastructure ensuring uninterrupted, competitively priced delivery of Pfizer medicines, vaccines and components while upholding stringent safety and efficacy standards
- Medicine Safety Resources: Comprehensive information service providing health literacy guides, treatment choices, safety tips, counterfeit alerts and data sheets to support safe prescribing and patient use.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Healthcare Pharmaceutical Distribution Solutions sector
M&A buyer group 1: Medical Device Distributors
12 companies
View group →
Description: Companies in Healthcare Medical Device Distribution Services specialize in channeling surgical instruments, implants, diagnostics, and disposable supplies from manufacturers to hospitals, IDNs, clinics, and surgery centers. They manage compliant warehousing, inventory control, and last‑mile delivery, often supporting consignment and kitting. The segment’s value is reliable availability, regulatory traceability, and procurement efficiency—characteristics analysts seek when evaluating strategic buyers in medical device distribution.
Owens & Minor
- Type: N/A
- Employees: ●●●●●
- Description: Provider of healthcare products and supply-chain services, Owens & Minor designs, manufactures and sources proprietary HALYARD, MediChoice and Medical Action infection-prevention and surgical products, while delivering customized distribution, logistics, inventory management and patient-direct home-healthcare solutions that reduce risks, improve efficiency and support superior patient outcomes.
- Key Products:
- HALYARD Infection-Prevention Products: Self-manufactured HALYARD brand supplies protect clinicians and patients with clinically superior surgical and infection-prevention solutions that meet rigorous safety and quality standards
- Distribution & Logistics Solutions: Customized supply chain programs place the right products in the right place at the right time, streamlining labor, lowering costs and ensuring uninterrupted quality care
- Supply Chain Services & Technology: On-site experts and proprietary technology maintain protocols, optimize inventory and improve workflow efficiency, freeing clinicians to focus on patient care
- Patient Direct Home Healthcare Delivery: Single-source service ships supplies for diabetes, ostomy, incontinence, wound and respiratory care, supporting seamless transition from hospital to home through an efficient delivery model.
🔒
🔒
🔒
View all 12 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Healthcare Pharmaceutical Distribution Solutions sector
3.1 - Buyout funds in the Healthcare Pharmaceutical Distribution Solutions sector
2.2 - Strategic buyer groups for Healthcare Pharmaceutical Distribution Solutions sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Healthcare Pharmaceutical Distribution Solutions companies
4.2 - Public trading comparable groups for Healthcare Pharmaceutical Distribution Solutions sector
Valuation benchmark group 1: Specialty B2B Distribution Companies
6 companies
View group →
Description: These public companies are specialty B2B wholesale distributors that aggregate, stock, and deliver category-specific products—pharmaceuticals, medical supplies, automotive and industrial parts, pool and outdoor products, specialty foods, and IT equipment—to professional customers. They monetize primarily through product sales augmented by value-added services and logistics. Grouped together as trading comparables given similar asset-light distribution models, inventory intensity, margin profiles, and recurring demand across fragmented end markets.
Genuine Parts
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of automotive and industrial replacement parts and value-added solutions with a global presence across North America, Europe, and Australasia. Engaged in distribution services through well-known brands like NAPA Auto Parts and Motion Industries, serving various markets with a broad range of parts and accessories.
- Key Products:
- Automotive Replacement Parts: Distribution of parts, accessories, and service items for automotive repairs
- Industrial Replacement Parts: Provision of machinery components and maintenance products
- Value-Added Solutions: Services like inventory management and supply chain optimization
- NAPA Auto Parts: Wide variety of automotive replacement parts and accessories
- Motion Industries: Industrial products and services supporting manufacturing and maintenance operations
🔒
🔒
🔒
View all 6 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →